INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
J P Morgan Global Alternatives, the Biotechnology Scam, and Tony Blair

J P Morgan Global Alternatives, the Biotechnology Scam, and Tony Blair

Let me know what you think in the comments...

Aug 29, 2024
∙ Paid
15

Share this post

INSIDE PHARMA
INSIDE PHARMA
J P Morgan Global Alternatives, the Biotechnology Scam, and Tony Blair
16
3
Share

Another cracking article from Fierce Pharma

J.P. Morgan's private financing arm closes inaugural $500M-plus biotech fund

By Gabrielle Masson, Jun 14, 2024 10:37am

“As the biotechnology industry enters the next era of scientific discovery, we strive to become a partner of choice for world-class researchers and entrepreneurs," Gaurav Gupta, M.D., managing partner of J.P. Morgan Life Sciences Private Capital, said.

The 270 fund closed above its $500 million target, though the exact figure was not disclosed.

J.P. Morgan Private Capital has a focus on growth investing and offers customized financing solutions for private companies. The team is a part of J.P. Morgan Asset Management’s alternative investment arm, known as J.P. Morgan Global Alternatives.

Global Alternatives, 03/19/2021

“We discuss our global alternatives platform across private equity, private debt, real assets and hedge funds and review our commitment to diversity.” In the corporate video, we hear from:

JPM Head, Global Alternative…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share